Aligos Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aligos Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $672k | 1.0M | 0.66 |
| 2023-09-30 | $755k | 1.0M | 0.75 |
| 2023-06-30 | $966k | 995k | 0.97 |
| 2023-03-31 | $889k | 1.0M | 0.87 |
| 2022-12-31 | $966k | 1.0M | 0.95 |
| 2022-06-30 | $1.3M | 1.1M | 1.21 |
| 2022-03-31 | $2.8M | 1.3M | 2.15 |
| 2021-09-30 | $20M | 1.3M | 15.51 |
| 2021-06-30 | $20M | 983k | 20.39 |
| 2021-03-31 | $14M | 615k | 22.77 |
| 2020-12-31 | $17M | 611k | 27.64 |